Dartmouth Cancer Center

Hoag Recruits Renowned Physician and Researcher from Dartmouth to Lead Hoag Neuro-Oncology Program

Retrieved on: 
Wednesday, August 30, 2023
Abstract, Surgeon, Tufts University School of Medicine, University, Hoag, Internal medicine, UNC, AUC, Endure to Cure Foundation, UNC Health Care, Duke University School of Medicine, Meningioma, Cancer, Research, Oncology, Immunotherapy, Glioblastoma, American College of Physicians, Radiation, Dartmouth, Dartmouth Cancer Center, Hematology, Geisel School of Medicine, Management, University of Washington School of Medicine, Diagnosis, Neuro, Cancer Management and Research, University of Missouri–Kansas City School of Medicine, American College, Medical imaging, Nursing, Physician, Brain, Medicine

NEWPORT BEACH, Calif. , Aug. 30, 2023 /PRNewswire/ -- Hoag is proud to announce that Simon Khagi, M.D., F.A.C.P., a renowned, triple board-certified medical oncologist and neuro-oncologist specializing in primary and metastatic brain cancers and spinal cord tumors, has joined the Hoag Family Cancer Institute as the director of neuro-oncology.

Key Points: 
  • Under Dr. Khagi's leadership, Hoag's Brain & Spine Tumor program will further its offerings in diagnosis, management and research, rivaling major academic medical centers.
  • "Dr. Khagi brings specialized expertise and research accomplishments that few physicians in the country can offer," said Burton Eisenberg, M.D., Grace E. Hoag Executive Medical Director Endowed Chair, Hoag Family Cancer Institute.
  • "His unique expertise in neuro-oncology is another example of how Hoag is highly committed to bringing the highest level of talent and innovation to our community."
  • Dr. Khagi joins Hoag after serving as regional medical director at Dartmouth Cancer Center in southern New Hampshire.

Citadel Credit Union Commits to Donating $1 Million to Children's Hospital of Philadelphia With Renewal of Parkway Run & Walk Sponsorship

Retrieved on: 
Wednesday, August 23, 2023
Run, Parkway, Partnership, Senior, CHOP, Benjamin Franklin Parkway, Children's Hospital of Philadelphia, Research, Dartmouth Cancer Center, Organization, American City Business Journals, MD, Division, Hospital, Patient, Citadel Credit Union, Health, Childhood cancer, Pharmaceutical industry, Nursing, Child, Citadel, Delaware Valley

EXTON, Pa., Aug. 23, 2023 /PRNewswire/ -- Citadel Credit Union has announced it will renew its longstanding, award-winning partnership with Children's Hospital of Philadelphia (CHOP) by signing on as presenting sponsor of the CHOP Parkway Run & Walk through 2027. Through this sponsorship, Citadel has committed to donating at least $1 million over four years to support breakthrough pediatric cancer research at the Cancer Center at CHOP.

Key Points: 
  • EXTON, Pa., Aug. 23, 2023 /PRNewswire/ -- Citadel Credit Union has announced it will renew its longstanding, award-winning partnership with Children's Hospital of Philadelphia (CHOP) by signing on as presenting sponsor of the CHOP Parkway Run & Walk through 2027.
  • Through this sponsorship, Citadel has committed to donating at least $1 million over four years to support breakthrough pediatric cancer research at the Cancer Center at CHOP .
  • Citadel Cares will be dedicated to supporting philanthropic efforts across the Greater Philadelphia area that help people and communities prosper, including the Parkway Run & Walk and associated fundraising efforts.
  • To learn more about Citadel's partnership with CHOP and to register or donate for the 2023 Parkway Run, visit CitadelBanking.com/CHOP .

The V Foundation for Cancer Research Announces the First Class of A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research

Retrieved on: 
Tuesday, June 27, 2023
Pancreatic cancer, Tobacco Products Scientific Advisory Committee, VCU Massey Cancer Center, Male, University, Mohammed V Foundation for Solidarity, Cancer research, COVID-19, NYU, Cancer, Jim Valvano, CDK7, Woman, Research, Salk Institute for Biological Studies, RNA, Assistant, Science, Cooper University Hospital, UCSF, Patient, Cancer Treatment Centers of America, Engineering, Melanoma, Dartmouth Cancer Center, Washington University School of Medicine, University of British Columbia, Ovarian cancer, Aichi M6A, Female, Prostate cancer, Dana–Farber Cancer Institute, Pharmaceutical industry, Nursing, Vaccine, Birth control, Doctor of Philosophy, MD

CARY, N.C., June 27, 2023 /PRNewswire/ -- The V Foundation for Cancer Research, a premier cancer research charity, proudly announces the first recipients of A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research. This landmark initiative is helping to counteract longstanding gender disparities in research by investing $8 million in the groundbreaking work of 11 women scientists leading the charge in cancer research.

Key Points: 
  • CARY, N.C., June 27, 2023 /PRNewswire/ -- The V Foundation for Cancer Research, a premier cancer research charity, proudly announces the first recipients of A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research.
  • We are not only advancing vital cancer research, but we're working to encourage more women to pursue careers in science.
  • The setbacks endured throughout the pandemic will have long-term for women in cancer research.
  • Recognizing these disparities, the V Foundation for Cancer Research developed A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research to amplify female representation and encourage more women-led breakthroughs in this field.

El Camino Health Launches Innovation Fund to Invest in New Healthcare Technology to Advance Patient Care

Retrieved on: 
Tuesday, June 20, 2023
Magnet, Communication, Food, Infection, AUC, Anxiety, Hope, Medicine, Research, Dartmouth Cancer Center, Google Images, Pain, Mountain View Hospital (Payson, Utah), Documentation, Patient, Physician, Machine learning, Pamela, Nursing research, Artificial intelligence, Mountain View Hospital, Health, Mental health, Nursing, Medical imaging

MOUNTAIN VIEW, Calif., June 20, 2023 /PRNewswire/ -- Today, El Camino Health announces the launch of a healthcare innovation fund, which will enable the health system to stay at the forefront of new healthcare technology and continue to adopt the latest and best practices to improve patient care. The fund was made possible by a generous gift by local philanthropists Pamela and Edward Taft.

Key Points: 
  • "At El Camino Health, our priority is to provide the most advanced science of medicine and continuously improve our services and patient outcomes," said Dan Woods, chief executive officer at El Camino Health.
  • El Camino Health is recognized as a pioneer of best practices that improve care, including recently integrating mental health assessments into mother-baby care.
  • "We're so proud that El Camino Health is a locally-based health system empowered by the technology typical of larger academic medical centers," Edward Taft said.
  • "And, we're thrilled to be able to advance the important work El Camino Health is doing to improve care in our community.

Oncology Ventures Invests in the Next Generation of Cancer Startups

Retrieved on: 
Wednesday, May 3, 2023
Universe, Survivor, Radiation, Life, Friends, Cancer, Quality of life, Partner (business rank), Research, Oncology, National Cancer Institute, Estate (law), City, Patient, Physician, Investment, Machine learning, Memorial Sloan Kettering Cancer Center, Medicine, Hematology, Artificial intelligence, Diagnosis, Breast cancer, Family, Dartmouth Cancer Center, Cryptocurrency, Video game, Pharmaceutical industry, Medical imaging, Hope, Ernest Freeberg

NEW YORK, May 3, 2023 /PRNewswire/ -- Oncology Ventures is the trusted partner for early stage cancer startups. The seed stage venture capital fund invests in data and infrastructure startups that make cancer care more affordable, efficient and accessible.

Key Points: 
  • NEW YORK, May 3, 2023 /PRNewswire/ -- Oncology Ventures is the trusted partner for early stage cancer startups.
  • The seed stage venture capital fund invests in data and infrastructure startups that make cancer care more affordable, efficient and accessible.
  • The Oncology Ventures team has already met with 250+ early stage cancer startups and is proud to announce its investments in:
    VivorCare : A fully-integrated cancer survivorship platform that is improving survivorship care for the 17M+ cancer survivors in the U.S.
    Gabbi : An early detection platform for breast cancer that aims to make late-stage breast cancer obsolete.
  • Oncology Ventures is excited to invest in and support cancer startups that will improve care outcomes and reduce costs, bringing true value-based care to cancer.

Ismael Cala Beams from India to Mexico for Wellness Event

Retrieved on: 
Friday, April 28, 2023
AT&T, CES, Major League Soccer, Education, AT, Marketing, Red Bull, PwC, Philip Morris, BT, Human, Harvard University, CBS Sports, CNN, Mindfulness, Silicon, Name, Entrepreneurship, Digital health, Guinness, Latin, Dartmouth Cancer Center, Proto, Verizon Communications, Health, Coca-Cola, Netflix, Social media, Nightclub, Mobile phone, Ferrari, Audi

Mexico City, April 28, 2023 (GLOBE NEWSWIRE) -- The  Life and business strategist, best-selling author, and international speaker and former CNN anchor Ismael Cala will beam from New Delhi, India to Mexico City via Proto hologram on Saturday.

Key Points: 
  • Mexico City, April 28, 2023 (GLOBE NEWSWIRE) -- The  Life and business strategist, best-selling author, and international speaker and former CNN anchor Ismael Cala will beam from New Delhi, India to Mexico City via Proto hologram on Saturday.
  • At Latin America’s largest health and wellness summit, EXMA Holistic 2023 , Fernando Anzures, Founder and CEO of EXMA, will lead a conversation with Cala on personal development and unlocking your potential.
  • EXMA Holistic 2023 is regarded as the most important wellness event in Mexico, covering fitness, mindfulness and a new approach to healthy living.
  • “Even though Ismael will be 9 thousand miles away, the Proto hologram will make it feel as if he’s really in the room with me and EXMA guests,” said Anzures.

Capital Health Cancer Center Approved as a Participating National Cancer Institute Community Oncology Research Program Site

Retrieved on: 
Wednesday, April 12, 2023
Heart, Quality of life, Research, Science, AHCC, Hopewell, Patient, Academic medical centre, Physician, Capital Health Regional Medical Center, Capital Health, NCI, Dartmouth Cancer Center, Pharmaceutical industry, Nursing, Mercer

PENNINGTON, N.J., April 12, 2023 /PRNewswire/ -- Capital Health Medical Center – Hopewell is now a NCI Community Oncology Research Program (NCORP) affiliate site of the Atlantic Health Cancer Consortium (AHCC).

Key Points: 
  • PENNINGTON, N.J., April 12, 2023 /PRNewswire/ -- Capital Health Medical Center – Hopewell is now a NCI Community Oncology Research Program (NCORP) affiliate site of the Atlantic Health Cancer Consortium (AHCC).
  • "On behalf of the entire organization, I am excited to welcome Capital Health Medical Center – Hopewell to Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP), the only New Jersey-based NCI Community Oncology Research Program (NCORP)," said Dr. Eric Whitman, principal investigator at AHCC CORP and medical director of Atlantic Health System Cancer Care.
  • To help connect patients to advanced care options, research staff at Capital Health Cancer Center will select trials from the NCORP research portfolio that may benefit the Center's patient population.
  • When a match is made, a primary investigator is appointed, and Capital Health research staff open the trial for Capital Health Cancer Center patients.

Rakuten Medical to Host Research & Development Day on Investigational Alluminox™ Platform

Retrieved on: 
Wednesday, March 1, 2023
Thomas Jefferson University, Light, Dartmouth Cancer Center, Patient, MD, SAN, Head, United, Safety, Development, Neoplasm, Pharmaceutical industry

SAN DIEGO, March 1, 2023 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing precision, cell-targeting therapies based on its proprietary photoimmunotherapy technology Alluminox™ platform, today announced that it will host a Research & Development Day on Thursday, March 16, 2023 from 12:30 p.m. – 2:00 p.m. ET / 9:30 a.m. – 11:00 a.m. PT.  This virtually held event will showcase the possibilities of Rakuten Medical's oncology technology and its lead investigational compound ASP-1929 for investors.

Key Points: 
  • SAN DIEGO, March 1, 2023 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing precision, cell-targeting therapies based on its proprietary photoimmunotherapy technology Alluminox™ platform, today announced that it will host a Research & Development Day on Thursday, March 16, 2023 from 12:30 p.m. – 2:00 p.m.
  • This virtually held event will showcase the possibilities of Rakuten Medical's oncology technology and its lead investigational compound ASP-1929 for investors.
  • Rakuten Medical's management team will also share their most updated pipeline status and further geographic and indicational expansion.
  • Please note that this event is for investors or financial institutions, and practicing healthcare professionals and patients are not permitted to attend.